Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...
Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.
Tiffin-area school children listen as Mayor Tim Kasparek speaks Sept. 16, 2025, during the groundbreaking ceremony of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results